Vadastuximab talirine plus hypomethylating agents: A well-tolerated regimen with high remission rate in frontline older patients with acute myeloid leukemia Meeting Abstract
| Authors: | Ravandi, F.; Stein, A.; Erba, H.; Lancet, J.; Stein, E.; Faderl, S.; Walter, R.; Advani, A.; DeAngelo, D.; Kovacsovics, T.; Jillella, A.; Bixby, D.; Levy, M.; O'Meara, M.; Ho, P.; Fathi, A. |
| Abstract Title: | Vadastuximab talirine plus hypomethylating agents: A well-tolerated regimen with high remission rate in frontline older patients with acute myeloid leukemia |
| Meeting Title: | 22nd Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 102 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Jun 22-25 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2017-06-26 |
| Start Page: | 48 |
| End Page: | 49 |
| Language: | English |
| ACCESSION: | WOS:000404127001099 |
| PROVIDER: | wos |
| PMCID: | PMC5492673 |
| Notes: | Meeting Abstract: P201 -- Source: Wos |
MSK Authors
-
342Stein